At last, the MAPK15 has been reported to be a regulator for redioresistance in nasopharyngeal carcinoma cells, which is tightly linked to the Epstein-Barr virus (EBV) infection (Li et al., 2018), which may relate to the EBV subtype of STAD. This evidence concerns the gene MAPK15 and Epstein-Barr virus infection.